Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference
Rhea-AI Summary
Integra LifeSciences (Nasdaq: IART) announced that CEO Mojdeh Poul and CFO Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025 at 10:30 a.m. ET. A live webcast will be available on the company investor relations website under Events & Presentations.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, IART gained 0.77%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
IART was up 3.64% while close peers were mixed to negative, including SSII at -3.8%, AHCO at -0.15%, ESTA at -0.36%, INMD at -0.14%, and BBNX at +0.45%, indicating a stock-specific move rather than a sector-wide shift.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 01 | Investor conference | Neutral | +0.8% | Management scheduled to present at Citi 2025 Global Healthcare Conference. |
| Nov 25 | Reimbursement update | Positive | +6.2% | Medicare rules expanded uniform reimbursement for multiple Integra skin substitutes. |
| Nov 11 | Regulatory clearance | Positive | +1.2% | FDA 510(k) clearance extended CUSA Clarity use to cardiac surgeries. |
| Oct 30 | Quarterly earnings | Positive | -23.5% | Q3 2025 showed revenue and EPS growth but stock fell sharply. |
| Oct 15 | Earnings call notice | Neutral | -1.2% | Announcement of Q3 2025 results release and conference call timing. |
Recent positive regulatory and reimbursement updates often saw gains, but the latest earnings release coincided with a sharp decline.
This announcement follows several material developments for Integra LifeSciences in late 2025. On Nov 25, the company highlighted Medicare policy changes that improved reimbursement for its wound products, and on Nov 11 it received FDA 510(k) clearance expanding CUSA Clarity’s use to cardiac surgery. However, Q3 2025 results on Oct 30 triggered a -23.46% move despite revenue and EPS growth. Against this backdrop, the Citi conference appearance on Dec 3, 2025 is a routine investor-relations event rather than a new fundamental catalyst.
Market Pulse Summary
This announcement highlights Integra LifeSciences’ participation in the Citi 2025 Global Healthcare Conference on December 3, 2025, giving management another platform to engage with investors. It follows recent Medicare reimbursement improvements and an FDA 510(k) clearance, as well as a volatile reaction to Q3 2025 results. Investors may focus on how management frames growth, margin trajectory, and capital allocation during the presentation and subsequent disclosures.
AI-generated analysis. Not financial advice.
PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025 at 10:30 a.m ET
A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.
About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit www.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
FAQ
When will Integra LifeSciences (IART) present at the Citi 2025 Global Healthcare Conference?
Who from Integra LifeSciences (IART) will present at the Citi 2025 Global Healthcare Conference?
How can investors watch Integra LifeSciences (IART) presentation at the Citi 2025 Global Healthcare Conference?
Will Integra LifeSciences (IART) provide presentation slides or replay from the Citi 2025 Global Healthcare Conference?
What topics will Integra LifeSciences (IART) cover in the Citi 2025 Global Healthcare Conference presentation?
Where on the Integra LifeSciences (IART) website is the Citi conference webcast hosted?
